Cai X, She M, Xu M, Chen H, Li J, Chen X, Zheng D, Liu J, Chen S, Zhu J
Therapies based on glucagon-like peptide-1 (GLP-1) reduce rates of cardiovascular and chronic kidney disease in people with type 2 diabetes and/or obesity, with ongoing clinical trials investigating their effects in people with metabolic liver disease, arthritis, and both substance use and neurodegenerative disorders
Some clinics have that and getting a DEXA scan, just know your bone health because [00:33:00] there are people who go on GP GLP ones, they don't eat enough and they start losing their bone
DOI: 10.1177/23247096231158954 36
Glycine: 2 grams before bed to enhance sleep quality and aid in muscle recovery
Mol Cell Biochem 234235: 239248 Koike Y, Hisada T, Utsugi M, Ishizuka T, Shimizu Y, Ono A, Murata Y, Hamuro J, Mori M, Dobashi K 2007 Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice